Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
MPRX, Inc. dba Medical Park Pharmacy is recalling T3/T4 SR 9 mcg/38 mcg capsules due to incorrect or missing lot and expiration dates and the use of expired components.
MPRX, Inc. dba Medical Park Pharmacy is recalling Tadalafil 20 mg Troche because the products were compounded using expired components and have incorrect or missing lot and expiration dates.
MPRX, Inc. dba Medical Park Pharmacy is recalling Lidocaine/Prilocaine/PE cream jars compounded with expired components and mislabeled.
MPRX, Inc. dba Medical Park Pharmacy is recalling Finasteride/Biotin 1 mg/50 mcg compounded using expired components and with incorrect or missing lot and expiration dates.
MPRX, Inc. is recalling Progesterone 200 mg Troche due to incorrect labeling and the use of expired components in compounding.
MPRX, Inc. dba Medical Park Pharmacy is recalling Sildenafil 80 mg capsules compounded with expired components and incorrect labeling.
Macleods Pharma USA is recalling 10,680 bottles of Montelukast Sodium Chewable Tablets, 5 mg, because testing revealed low out-of-specification dissolution results in one lot.
MPRX, Inc. is recalling Magic Bullet Supplement bottles compounded with expired components and incorrect labeling. The recall affects products distributed in Texas.
MPRX, Inc. dba Medical Park Pharmacy is recalling Liothyronine (T3) 80 mcg SR capsules compounded with expired components and missing labeling.
MPRX, Inc. dba Medical Park Pharmacy is recalling Testosterone Topical Cream 4% because it was compounded using expired components and has incorrect or missing lot and expiration dates.
MPRX, Inc. is recalling Progesterone 50 mg capsules compounded with expired components due to incorrect or missing lot and expiration dates.
MPRX, Inc. dba Medical Park Pharmacy is recalling Naltrexone 4.5 mg capsules because they were compounded using expired components and have incorrect or missing lot and expiration dates.
MPRX, Inc. dba Medical Park Pharmacy is recalling DHEA/Pregnenol One 10.25 MG Capsules because they were compounded using expired components and have incorrect or missing lot and expiration dates.
Preferred Pharmaceuticals is recalling Ranitidine Tablets, 300 mg, because the presence of the NDMA impurity was detected in the product.
Preferred Pharmaceuticals is recalling 150 mg Ranitidine tablets because of detected NDMA impurity. The affected products were distributed to physicians in seven states.
H.J. Harkins Company is recalling specific lots of Ranitidine 150 mg tablets because NDMA impurity was detected. The product was distributed to physicians in four states.
Entropic Labs is recalling SARM RAD-140 capsules because they were marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
Denton Pharma is recalling 467 bottles of Ranitidine Tablets 300 mg because of the presence of NDMA impurity. The affected products were distributed nationwide.
Mylan Pharmaceuticals is recalling Nizatidine Capsules 150 mg because trace amounts of the impurity NDMA were detected in the active ingredient.
RemedyRepack Inc. is recalling specific lots of Ranitidine 150 mg tablets because the supplier reported potential Nitrosodimethylamine (NDMA) levels above established limits.
Denton Pharma is recalling 1,341 bottles of Ranitidine Tablets 150 mg because the product was found to contain the NDMA impurity.
Mylan Pharmaceuticals is recalling Nizatidine Capsules 300 mg because trace amounts of the impurity NDMA were detected in the active ingredient.
Hikma Pharmaceuticals is recalling 4,840 vials of Methylprednisolone Sodium Succinate Injection because the label incorrectly instructs healthcare professionals to reconstitute the product with 16 mL instead of 8 mL.
Advanced Accelerator Applications USA, Inc. is recalling NETSPOT kits because the dilution buffer vial has a loose aluminum cap crimp.
Motto International Corp is recalling Bull Platinum 30000 Capsules because FDA analysis found the product contains tadalafil, a prescription drug, and it was marketed without an approved NDA or ANDA.